Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $4,885 | $4,792 | $4,881 | $5,085 |
| % Growth | 1.9% | -1.8% | -4% | – |
| Cost of Goods Sold | $3,643 | $3,577 | $3,697 | $3,814 |
| Gross Profit | $1,242 | $1,214 | $1,184 | $1,271 |
| % Margin | 25.4% | 25.3% | 24.3% | 25% |
| R&D Expenses | $38 | $38 | $43 | $50 |
| G&A Expenses | $0 | $608 | $560 | $0 |
| SG&A Expenses | $705 | $792 | $751 | $840 |
| Sales & Mktg Exp. | $0 | $184 | $190 | $0 |
| Other Operating Expenses | $23 | -$41 | $58 | $121 |
| Operating Expenses | $766 | $789 | $853 | $1,011 |
| Operating Income | $477 | $425 | $331 | $259 |
| % Margin | 9.8% | 8.9% | 6.8% | 5.1% |
| Other Income/Exp. Net | -$74 | -$75 | -$81 | -$79 |
| Pre-Tax Income | $403 | $351 | $251 | $180 |
| Tax Expense | $75 | $78 | $61 | $61 |
| Net Income | $275 | $225 | $151 | $67 |
| % Margin | 5.6% | 4.7% | 3.1% | 1.3% |
| EPS | 0.47 | 0.39 | 0.26 | 0.06 |
| % Growth | 20.5% | 50% | 333.3% | – |
| EPS Diluted | 0.47 | 0.39 | 0.26 | 0.06 |
| Weighted Avg Shares Out | 585 | 587 | 587 | 1,174 |
| Weighted Avg Shares Out Dil | 585 | 587 | 587 | 1,174 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $22 | $15 | $22 |
| Interest Expense | $74 | $97 | $96 | $101 |
| Depreciation & Amortization | $395 | $375 | $394 | $0 |
| EBITDA | $871 | $822 | $741 | $281 |
| % Margin | 17.8% | 17.2% | 15.2% | 5.5% |